Activation of Thioglycosides
421
Typical glycosylation protocol. A stirred solution of substrate, BSP (1.1
˚
equiv.), TTBP (2.0 equiv.) and 3 A sieves in CH Cl (0.03 M in substrate) was
2
2
kept at –788C for 15 min. Then Tf O (1.2 equiv.) was added and after 5 min.
2
the acceptor (1.5 equiv.) in CH Cl (2.0 M) was added. Stirring was continued
2
2
at –788C for 0.5 hr and then the reaction mixture was allowed to warm to rt
over a period of 2 hr before it was filtered, washed with a saturated solution
of NaHCO and brine, dried, and concentrated. Chromatographic purification
3
(
eluting with mixtures of ethyl acetate in hexane) afforded the coupled
products.
Methyl 2,3,6-tri-O-benzyl-4-O-(2,3-di-O-dibenzyl-b-D-mannopyranosyl)-
a-D-glucopyranoside (18). This compound was prepared by the standard
2
0
1
protocol and had the following characteristics: [a] –17.1 (c, 0.75); H NMR
D
(
(
(
500 MHz) d: 7.50–7.48 (m, 2H), 7.42–7.17 (m, 28H), 5.52 (s, 1H), 5.08–5.04
d, J ¼ 11.0 Hz, 1H), 4.86–4.79 (m, 3H), 4.77 (s, 1H), 4.73 (s, 1H), 4.66–4.56
m, 4H), 4.36 (s, 1H), 4.30–4.26 (d, J ¼ 12.0 Hz, 1H), 4.14–4.02 (m, 2H),
3
.93–3.83 (m, 2H), 3.64–3.58 (m, 2H), 3.54–3.47 (m, 3H), 3.44–3.43
(
d, J ¼ 3.0 Hz, 1H), 3.41 (s, 3H), 3.45–3.31 (dd, J ¼ 3.3, 9.6 Hz, 1H), 3.09–
13
3
1
1
7
9
.01 (m, 1H); C NMR (125 MHz) d: 139.9, 139.1, 139.0, 138.8, 138.1, 138.0,
29.3, 129.0, 128.8, 128.7, 128.6, 128.5, 128.2, 128.1, 128.0, 127.9, 127.8,
26.7, 101.9, 101.7, 98.8, 80.7, 79.4, 79.1, 78.7, 78.1, 75.7, 75.4, 74.1, 72.5,
þ
0.0, 69.0, 68.8, 67.7, 55.8; ESI-HRMS calcd. for C H O Na [M þ Na] :
55
58 11
17.3877. Found 917.3871.
1
,2:3,4-Di-O-isopropylidene-3-O-(2,3,4,6-tetra-O-benzoyl-b-D-b-galacto-
pyranosyl)-a-D-galactopyranose (21). This compound was prepared by the
2
6
standard protocol and had the following characteristics: [a] þ 34.78 (c, 3.0),
D
[
33]
1
lit.
[a] ¼ þ 458 (CHCl ); H NMR (500 MHz) d: 8.09 (d, J ¼ 7.6 Hz, 2H),
D
3
8
7
.03 (d, J ¼ 7.7 Hz, 2H), 7.98 (d, J ¼ 7.7 Hz, 2H), 7.79 (d, J ¼ 7.7 Hz, 2H),
.23–7.49 (m, 12H), 6.00 (d, J ¼ 2.8 Hz, 1H), 5.82 (t, J ¼ 10.0 Hz, 1H), 5.62
(
dd, J ¼ 3.2, 10.4 Hz, 1H), 5.42 (d, J ¼ 4.9 Hz, 1H), 5.03 (d, J ¼ 8.0 Hz, 1H),
4
4
1
1
1
7
.68 (dd, J ¼ 6.6, 11.2 Hz, 1H), 4.41–4.45 (m, 2H), 4.35 (t, J ¼ 6.5 Hz, 1H),
.22 (d, J ¼ 2.7 Hz, 1H), 4.05–4.12 (m, 2H), 3.90–3.93 (m, 2H), 1.40 (s, 3H),
1
3
.24 (s, 3H), 1.22 (s, 3H), 1.20 (s, 3H); C NMR (125 MHz) d: 166.0, 165.6,
65.3, 133.6, 133.2, 133.0, 130.02, 129.98, 129.79, 129.4, 129.3, 129.0, 128.8,
28.6, 128.4, 128.3, 128.2, 124.8, 109.3, 108.4, 101.7, 96.2, 71.8, 71.3, 71.0,
0.5, 70.3, 69.7, 68.4, 68.2, 67.4, 62.4, 62.0, 25.9, 25.7, 24.8, 24.2.
1
,2:5,6-Di-O-isopropylidene-3-O-(2,3,4,6-tetra-O-benzoyl-b-D-b-galacto-
[
34]
pyranosyl)-a-D-glucofuranose (22).
This compound was prepared by the
[
24]
standard protocol and had the following characterisitcs: [a]
þ46.1 (c, 1.8);
D
1
H NMR (500 MHz) d: 8.10–8.08 (d, J ¼ 7.5 Hz, 2H), 8.04–8.02 (d, J ¼ 8.0 Hz,
2
H), 8.00–7.94 (d, J ¼ 8.0 Hz, 2H), 7.79–7.77 (d, J ¼ 7.5 Hz, 2H), 7.63–7.60
(
t, J ¼ 7.5 Hz, 1H), 7.58–7.55 (t, J ¼ 7.5 Hz, 1H), 7.51–7.41 (m, 6H),